| 2019 | A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients | BREAST CANCER RESEARCH AND TREATMENT |
| 2021 | Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer
| CANCERS |
| 2014 | Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2024 | Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
| YONSEI MEDICAL JOURNAL |
| 2017 | In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost
| RADIATION ONCOLOGY JOURNAL |
| 2021 | Intraoperative radiation therapy induces immune response activity after pancreatic surgery
| BMC CANCER |
| 2022 | Intraoperative Radiotherapy for Resectable Pancreatic Cancer Using a Low-Energy X-Ray Source: Postoperative Complications and Early Outcomes
| YONSEI MEDICAL JOURNAL |
| 2021 | Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches | PANCREATOLOGY |
| 2018 | Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective | CLINICAL BREAST CANCER |
| 2017 | Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea
| JOURNAL OF BREAST CANCER |
| 2012 | Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer. | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2018 | Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial | ANNALS OF SURGERY |
| 2020 | Phase I Radiation Dose-Escalation Study to Investigate the Dose-Limiting Toxicity of Concurrent Intra-Arterial Chemotherapy for Unresectable Hepatocellular Carcinoma
| CANCERS |
| 2014 | Postoperative radiotherapy dose correlates with locoregional control in patients with locoregional control in patients with extra-hepatic bile duct cancer
| RADIATION ONCOLOGY JOURNAL |
| 2023 | Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer
| FRONTIERS IN ONCOLOGY |
| 2016 | Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2019 | Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment | ANNALS OF SURGICAL ONCOLOGY |
| 2021 | Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective | ANNALS OF SURGERY |
| 2016 | Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients
| CANCER RESEARCH AND TREATMENT |
| 2020 | Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
| FRONTIERS IN ENDOCRINOLOGY |
| 2019 | The Effect of Nutrition Intervention with Oral Nutritional Supplements on Pancreatic and Bile Duct Cancer Patients Undergoing Chemotherapy
| NUTRIENTS |
| 2009 | Validation of Radiation Volume by Analysis of Recurrence Pattern in Breast-conserving Treatment for Early Breast Cancer
| JOURNAL OF BREAST CANCER |
